Production (Stage)
Molecular Partners AG
MOLN
$3.87
-$0.1314-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -72.63% | 271.50% | -4.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -72.63% | 271.50% | -4.99% |
| Cost of Revenue | -17.80% | -20.01% | -4.42% | 11.84% | 17.58% |
| Gross Profit | -2.01% | 12.42% | -14.69% | -2.23% | -24.72% |
| SG&A Expenses | -8.61% | -6.60% | 1.72% | -5.41% | -12.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.58% | -15.63% | -2.73% | 6.90% | 8.51% |
| Operating Income | 1.00% | 10.40% | -10.44% | 0.01% | -11.24% |
| Income Before Tax | -44.04% | 42.75% | -46.43% | 6.22% | 18.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.03% | 42.74% | -46.43% | 6.22% | 18.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.03% | 42.74% | -46.43% | 6.22% | 18.89% |
| EBIT | 1.00% | 10.40% | -10.44% | 0.01% | -11.24% |
| EBITDA | 0.59% | 10.65% | -10.93% | -0.02% | -11.50% |
| EPS Basic | -28.37% | 48.99% | -44.88% | 7.22% | 19.65% |
| Normalized Basic EPS | -28.38% | 49.00% | -44.87% | 7.24% | 19.67% |
| EPS Diluted | -28.37% | 48.68% | -44.88% | 7.22% | 19.65% |
| Normalized Diluted EPS | -28.38% | 49.00% | -44.87% | 7.24% | 19.67% |
| Average Basic Shares Outstanding | 12.19% | 12.26% | 1.09% | 1.07% | 0.96% |
| Average Diluted Shares Outstanding | 12.19% | 12.26% | 1.09% | 1.07% | 0.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |